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Introduction.  Combined oral contraceptives (COC) are more and more used by fertile women, 
as well as teenagers in different cases, like dysmenorrhea, endometriosis, ovarian polycystic 
syndrome, dysfunctional uterine bleeding (DUB) and hormone-replacement therapy (HRT) for 
primary ovarian insufficiency. Even if they act efficiently in pregnancy prevention and 
hormonal regulation, they also significantly increase the risk of venous thromboembolism. 
Recent researches have shown that the risk of venous thromboembolism depends a lot on the 
ratio of estrogen/progestin in combined oral contraceptives and on thrombotic events of women 
on COC. 
Aim of the study.  Description of the mechanisms that can induce venous thromboembolism 
and the selection of women potentially predisposed to them. Highlighting the frequency of their 
occurrence depending on the ratio estrogen/progestin in the composition of combined oral 
contraceptive. Individual prescription for oral contraceptives, in order to reduce their risk for 
health. 
Materials and methods.  The literature analysis has been conducted using 98 bibliographic 
sources from PubMed search engine starting with January 2017 and from PMC since January 
2015. 
Results.  In women with mutation of Factor V Leiden and prothrombin, as well as defects of 
antithrombin III, protein C and S, that take hormonal contraceptives, the risk of venous 
thromboembolism increases up to 3-9%, unlike women who do not take them. Also, women 
who take oral contraceptives with estrogen and levonorgestrel, deriving from progestin, have 
a high level of Factor VII, X and fibrinogen, produced by high hepatic synthesis stimulated by 
the first hepatic degradation of estrogen, and high APC resistance and low level of 
antithrombine and protein S. Thus, favorable conditions for venous thromboembolism occur. 
Conclusions.  In women who take oral contraceptives the risk of thrombosis is higher than in 
women who do not take them. The mechanisms inducing venous thromboembolism depend a 
lot on the specific ratio of estrogen/progestin and the presence of hereditary or acquired 
thrombophilia in women on COC. 
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Introduction.  Ischemia is a pathological condition when the blood supply to a tissue is 
interrupted and may lead to irreversible damages due to lack of oxygen and nutrients. There 
are many diseases, such as myocardial infarction, ovarian torsion, ischemic stroke, where the 
